$RGLS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Regulus Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Regulus Therapeutics Inc.. Get notifications about new insider transactions in Regulus Therapeutics Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 02 2017 | RGLS | Regulus Therapeuti ... | FOLETTA MARK G | Director | Option Exercise | A | 1.45 | 30,000 | 43,500 | 30,000 | |
Jun 02 2017 | RGLS | Regulus Therapeuti ... | BALTIMORE DAVID | Director | Option Exercise | A | 1.45 | 30,000 | 43,500 | 30,000 | |
Jun 02 2017 | RGLS | Regulus Therapeuti ... | Witz Pascale | Director | Option Exercise | A | 1.45 | 60,000 | 87,000 | 60,000 | |
May 12 2017 | RGLS | Regulus Therapeuti ... | Chevallard Daniel R. | Chief Financial Off ... | Option Exercise | A | 1.65 | 100,000 | 165,000 | 100,000 | |
May 08 2017 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Option Exercise | A | 1.70 | 750,000 | 1,275,000 | 750,000 | |
May 08 2017 | RGLS | Regulus Therapeuti ... | WRIGHT TIMOTHY MICHAEL | Chief R & D Officer | Option Exercise | A | 1.70 | 350,000 | 595,000 | 350,000 | |
Mar 23 2017 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Buy | P | 1.23 | 300,000 | 368,100 | 700,677 | 400.7 K to 700.7 K (+74.87 %) |
Mar 23 2017 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Buy | P | 1.20 | 200,000 | 239,800 | 400,677 | 200.7 K to 400.7 K (+99.66 %) |
Mar 07 2017 | RGLS | Regulus Therapeuti ... | RASTETTER WILLIAM H | Director | Buy | P | 1.15 | 250,000 | 287,500 | 350,000 | 100 K to 350 K (+250.00 %) |
Feb 23 2017 | RGLS | Regulus Therapeuti ... | WRIGHT TIMOTHY MICHAEL | Chief R & D Officer | Option Exercise | A | 1.20 | 32,412 | 38,894 | 32,412 | |
Feb 23 2017 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | Chief Operating Off ... | Option Exercise | A | 1.20 | 160,000 | 192,000 | 160,000 | |
Feb 23 2017 | RGLS | Regulus Therapeuti ... | GRINT PAUL C | President & CEO | Option Exercise | A | 1.20 | 410,000 | 492,000 | 410,000 | |
Feb 01 2017 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | Chief Operating Off ... | Option Exercise | A | 5.77 | 30,000 | 173,100 | 30,000 | |
Feb 01 2017 | RGLS | Regulus Therapeuti ... | GRINT PAUL C | President & CEO | Option Exercise | A | 6.35 | 130,000 | 825,500 | 130,000 | |
Oct 07 2016 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | Chief Operating Off ... | Option Exercise | A | 3.52 | 59,625 | 209,880 | 59,625 | |
Oct 07 2016 | RGLS | Regulus Therapeuti ... | GRINT PAUL C | President & CEO | Option Exercise | A | 3.52 | 186,640 | 656,973 | 186,640 | |
Oct 05 2016 | RGLS | Regulus Therapeuti ... | WRIGHT TIMOTHY MICHAEL | Chief R & D Officer | Option Exercise | A | 3.30 | 450,000 | 1,485,000 | 450,000 | |
Jun 03 2016 | RGLS | Regulus Therapeuti ... | WILLIAMS DOUGLAS E | Director | Option Exercise | A | 6.20 | 36,620 | 227,044 | 36,620 | |
Jun 03 2016 | RGLS | Regulus Therapeuti ... | RASTETTER WILLIAM H | Director | Option Exercise | A | 6.20 | 36,620 | 227,044 | 36,620 | |
Jun 03 2016 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 6.20 | 36,620 | 227,044 | 36,620 | |
Jun 03 2016 | RGLS | Regulus Therapeuti ... | FOLETTA MARK G | Director | Option Exercise | A | 6.20 | 36,620 | 227,044 | 36,620 | |
Jun 03 2016 | RGLS | Regulus Therapeuti ... | BALTIMORE DAVID | Director | Option Exercise | A | 6.20 | 36,620 | 227,044 | 36,620 | |
Jun 03 2016 | RGLS | Regulus Therapeuti ... | Rosen Hugh | Director | Option Exercise | A | 6.20 | 70,952 | 439,902 | 70,952 | |
Mar 07 2016 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | Chief Operating Off ... | Buy | P | 7.19 | 10,000 | 71,900 | 10,000 | 0 to 10 K |
Feb 24 2016 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 7.18 | 1,000,000 | 7,180,000 | 4,896,716 | 5.9 M to 4.9 M (-16.96 %) |
Feb 05 2016 | RGLS | Regulus Therapeuti ... | GRINT PAUL C | President & CEO | Option Exercise | A | 6.35 | 265,000 | 1,682,750 | 265,000 | |
Jan 06 2016 | RGLS | Regulus Therapeuti ... | GRINT PAUL C | President & CEO | Option Exercise | A | 7.58 | 30,000 | 227,400 | 30,000 | |
Jan 06 2016 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | Chief Operating Off ... | Option Exercise | A | 8.57 | 420,000 | 3,599,400 | 420,000 | |
Aug 13 2015 | RGLS | Regulus Therapeuti ... | FOLETTA MARK G | Director | Buy | P | 7.64 | 10,000 | 76,405 | 10,000 | 0 to 10 K |
Aug 07 2015 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 2.66 | 15,677 | 41,701 | 1,823 | |
Aug 07 2015 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 1.74 | 17,500 | 30,450 | 0 | |
Aug 07 2015 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 0.38 | 17,500 | 6,650 | 0 | |
Aug 07 2015 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Buy | M | 2.66 | 15,677 | 41,701 | 200,677 | 185 K to 200.7 K (+8.47 %) |
Aug 07 2015 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Buy | M | 1.74 | 17,500 | 30,450 | 185,000 | 167.5 K to 185 K (+10.45 %) |
Aug 07 2015 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Buy | M | 0.38 | 17,500 | 6,650 | 167,500 | 150 K to 167.5 K (+11.67 %) |
Jul 21 2015 | RGLS | Regulus Therapeuti ... | RASTETTER WILLIAM H | Director | Buy | P | 10.19 | 61,235 | 624,199 | 100,000 | 38.8 K to 100 K (+157.96 %) |
Jul 21 2015 | RGLS | Regulus Therapeuti ... | RASTETTER WILLIAM H | Director | Buy | P | 10.13 | 38,765 | 392,779 | 38,765 | 0 to 38.8 K |
Jul 17 2015 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | 10% Owner | Sell | S | 10.21 | 111,000 | 1,133,754 | 5,173,172 | 5.3 M to 5.2 M (-2.10 %) |
Jul 17 2015 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | 10% Owner | Sell | S | 10.79 | 167,000 | 1,801,362 | 5,284,172 | 5.5 M to 5.3 M (-3.06 %) |
Jul 17 2015 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | 10% Owner | Sell | S | 10.76 | 65,133 | 700,961 | 5,451,172 | 5.5 M to 5.5 M (-1.18 %) |
Jul 02 2015 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | 10% Owner | Sell | S | 10.79 | 13,248 | 143,010 | 5,516,305 | 5.5 M to 5.5 M (-0.24 %) |
Jul 02 2015 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | 10% Owner | Gift | G | 0.00 | 13,248 | 0 | 5,529,553 | 5.5 M to 5.5 M (+0.24 %) |
Jun 26 2015 | RGLS | Regulus Therapeuti ... | GRINT PAUL C | President & CEO | Option Exercise | A | 10.22 | 500,000 | 5,110,000 | 500,000 | |
Jun 26 2015 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 10.02 | 17,500 | 175,350 | 17,500 | |
Jun 26 2015 | RGLS | Regulus Therapeuti ... | FOLETTA MARK G | Director | Option Exercise | A | 10.02 | 17,500 | 175,350 | 17,500 | |
Jun 26 2015 | RGLS | Regulus Therapeuti ... | RASTETTER WILLIAM H | Director | Option Exercise | A | 10.02 | 17,500 | 175,350 | 17,500 | |
Jun 26 2015 | RGLS | Regulus Therapeuti ... | CARTER BRUCE L A | Director | Option Exercise | A | 10.02 | 17,500 | 175,350 | 17,500 | |
Jun 26 2015 | RGLS | Regulus Therapeuti ... | BALTIMORE DAVID | Director | Option Exercise | A | 10.02 | 17,500 | 175,350 | 17,500 | |
Jun 26 2015 | RGLS | Regulus Therapeuti ... | CARTER BRUCE L A | Director | Option Exercise | A | 10.02 | 17,500 | 175,350 | 17,500 | |
Jun 26 2015 | RGLS | Regulus Therapeuti ... | WILLIAMS DOUGLAS E | Director | Option Exercise | A | 10.02 | 17,500 | 175,350 | 17,500 | |
Apr 21 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 60,000 | 22,800 | 8,287 | |
Apr 21 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 66,071 | 25,107 | 68,287 | |
Apr 21 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 73,929 | 28,093 | 134,358 | |
Apr 21 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 17.73 | 60,000 | 1,063,980 | 3,705 | 63.7 K to 3.7 K (-94.18 %) |
Apr 21 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 60,000 | 22,800 | 63,705 | 3.7 K to 63.7 K (+1,619.43 %) |
Apr 21 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 16.85 | 66,071 | 1,113,514 | 3,705 | 69.8 K to 3.7 K (-94.69 %) |
Apr 21 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 66,071 | 25,107 | 69,776 | 3.7 K to 69.8 K (+1,783.29 %) |
Apr 21 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 16.94 | 73,929 | 1,252,002 | 3,705 | 77.6 K to 3.7 K (-95.23 %) |
Apr 21 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 73,929 | 28,093 | 77,634 | 3.7 K to 77.6 K (+1,995.38 %) |
Apr 14 2015 | RGLS | Regulus Therapeuti ... | CARTER BRUCE L A | Director | Option Exercise | M | 4.78 | 20,000 | 95,600 | 10,000 | |
Apr 14 2015 | RGLS | Regulus Therapeuti ... | CARTER BRUCE L A | Director | Sell | S | 17.66 | 20,000 | 353,164 | 0 | 20 K to 0 (-100.00 %) |
Apr 14 2015 | RGLS | Regulus Therapeuti ... | CARTER BRUCE L A | Director | Buy | M | 4.78 | 20,000 | 95,600 | 20,000 | 0 to 20 K |
Mar 05 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 89,230 | 33,907 | 208,287 | |
Mar 05 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 20.81 | 23,616 | 491,551 | 2,466 | 26.1 K to 2.5 K (-90.55 %) |
Mar 05 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 20.06 | 65,614 | 1,316,512 | 26,082 | 91.7 K to 26.1 K (-71.56 %) |
Mar 05 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 89,230 | 33,907 | 91,696 | 2.5 K to 91.7 K (+3,618.41 %) |
Mar 03 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 70 | 27 | 297,517 | |
Mar 03 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 19.50 | 70 | 1,365 | 2,466 | 2.5 K to 2.5 K (-2.76 %) |
Mar 03 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 70 | 27 | 2,536 | 2.5 K to 2.5 K (+2.84 %) |
Feb 03 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 2,400 | 912 | 297,587 | |
Feb 03 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 3,300 | 1,254 | 299,987 | |
Feb 03 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 19.77 | 2,400 | 47,440 | 2,466 | 4.9 K to 2.5 K (-49.32 %) |
Feb 03 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 2,400 | 912 | 4,866 | 2.5 K to 4.9 K (+97.32 %) |
Feb 03 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 19.50 | 3,300 | 64,351 | 2,466 | 5.8 K to 2.5 K (-57.23 %) |
Feb 03 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 3,300 | 1,254 | 5,766 | 2.5 K to 5.8 K (+133.82 %) |
Jan 30 2015 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Sell | S | 18.66 | 8,655 | 161,493 | 0 | 8.7 K to 0 (-100.00 %) |
Jan 30 2015 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Sell | S | 17.98 | 71,345 | 1,282,812 | 8,655 | 80 K to 8.7 K (-89.18 %) |
Jan 30 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 60,000 | 22,800 | 303,287 | |
Jan 30 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 85,000 | 32,300 | 363,287 | |
Jan 30 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 18.40 | 26,227 | 482,627 | 2,466 | 28.7 K to 2.5 K (-91.41 %) |
Jan 30 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 17.77 | 33,773 | 600,008 | 28,693 | 62.5 K to 28.7 K (-54.07 %) |
Jan 30 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 60,000 | 22,800 | 62,466 | 2.5 K to 62.5 K (+2,433.09 %) |
Jan 30 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 18.69 | 12,989 | 242,701 | 2,466 | 15.5 K to 2.5 K (-84.04 %) |
Jan 30 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 17.97 | 72,011 | 1,293,814 | 15,455 | 87.5 K to 15.5 K (-82.33 %) |
Jan 30 2015 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 85,000 | 32,300 | 87,466 | 2.5 K to 87.5 K (+3,446.88 %) |
Dec 15 2014 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Option Exercise | M | 0.38 | 150,000 | 57,000 | 0 | |
Dec 15 2014 | RGLS | Regulus Therapeuti ... | PAPADOPOULOS STELIOS | Director | Buy | M | 0.38 | 150,000 | 57,000 | 150,000 | 0 to 150 K |
Dec 04 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | A | 17.76 | 231,634 | 4,113,820 | 231,634 | |
Dec 04 2014 | RGLS | Regulus Therapeuti ... | Szekeres David Leslie | Chief Business Offi ... | Option Exercise | A | 17.76 | 81,101 | 1,440,354 | 81,101 | |
Dec 04 2014 | RGLS | Regulus Therapeuti ... | GRINT PAUL C | Chief Medical Offic ... | Option Exercise | A | 17.76 | 50,870 | 903,451 | 50,870 | |
Dec 04 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | A | 17.76 | 90,378 | 1,605,113 | 90,378 | |
Dec 01 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | M | 1.74 | 2,500 | 4,350 | 111,500 | |
Dec 01 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Sell | S | 19.63 | 1,500 | 29,445 | 80,000 | 81.5 K to 80 K (-1.84 %) |
Dec 01 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Sell | S | 18.80 | 1,000 | 18,800 | 81,500 | 82.5 K to 81.5 K (-1.21 %) |
Dec 01 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Buy | M | 1.74 | 2,500 | 4,350 | 82,500 | 80 K to 82.5 K (+3.13 %) |
Nov 14 2014 | RGLS | Regulus Therapeuti ... | ASTRAZENECA PLC | 10% Owner | Sell | S | 17.00 | 2,000,000 | 34,000,000 | 4,250,000 | 6.3 M to 4.3 M (-32.00 %) |
Nov 05 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | 10% Owner | Sell | S | 15.94 | 1,279,411 | 20,390,613 | 5,516,305 | 6.8 M to 5.5 M (-18.83 %) |
Oct 31 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 3,505 | 1,332 | 448,287 | |
Oct 31 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 20.41 | 100 | 2,041 | 2,466 | 2.6 K to 2.5 K (-3.90 %) |
Oct 31 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 19.78 | 2,005 | 39,659 | 2,566 | 4.6 K to 2.6 K (-43.86 %) |
Oct 31 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 18.66 | 1,400 | 26,124 | 4,571 | 6 K to 4.6 K (-23.45 %) |
Oct 31 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 3,505 | 1,332 | 5,971 | 2.5 K to 6 K (+142.13 %) |
Oct 31 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | M | 1.74 | 2,500 | 4,350 | 114,000 | |
Oct 31 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Sell | S | 20.41 | 200 | 4,082 | 80,000 | 80.2 K to 80 K (-0.25 %) |
Oct 31 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Sell | S | 19.67 | 1,200 | 23,604 | 80,200 | 81.4 K to 80.2 K (-1.47 %) |
Oct 31 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Sell | S | 18.68 | 1,100 | 20,548 | 81,400 | 82.5 K to 81.4 K (-1.33 %) |
Oct 31 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Buy | M | 1.74 | 2,500 | 4,350 | 82,500 | 80 K to 82.5 K (+3.13 %) |
Oct 24 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 15.19 | 1,850 | 28,109 | 6,795,716 | 6.8 M to 6.8 M (-0.03 %) |
Oct 24 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 14.24 | 1,700 | 24,202 | 6,797,566 | 6.8 M to 6.8 M (-0.03 %) |
Oct 24 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 14.00 | 109,534 | 1,533,125 | 6,799,266 | 6.9 M to 6.8 M (-1.59 %) |
Oct 24 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 15.19 | 1,850 | 28,109 | 5,896,716 | 5.9 M to 5.9 M (-0.03 %) |
Oct 24 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 14.24 | 1,700 | 24,202 | 5,898,566 | 5.9 M to 5.9 M (-0.03 %) |
Oct 24 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 14.00 | 109,534 | 1,533,125 | 5,900,266 | 6 M to 5.9 M (-1.82 %) |
Oct 22 2014 | RGLS | Regulus Therapeuti ... | Szekeres David Leslie | CBO and General Cou ... | Option Exercise | A | 8.51 | 40,000 | 340,400 | 40,000 | |
Oct 22 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | A | 6.13 | 40,000 | 245,200 | 40,000 | |
Oct 24 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | M | 1.74 | 3,300 | 5,742 | 116,500 | |
Oct 24 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Sell | S | 14.44 | 3,300 | 47,644 | 80,000 | 83.3 K to 80 K (-3.96 %) |
Oct 24 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Buy | M | 1.74 | 3,300 | 5,742 | 83,300 | 80 K to 83.3 K (+4.13 %) |
Oct 22 2014 | RGLS | Regulus Therapeuti ... | GRINT PAUL C | Chief Medical Offic ... | Option Exercise | A | 7.58 | 40,000 | 303,200 | 40,000 | |
Oct 22 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | A | 6.13 | 88,000 | 539,440 | 88,000 | |
Oct 21 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 300 | 114 | 451,792 | |
Oct 21 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 400 | 152 | 452,092 | |
Oct 21 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 7.00 | 300 | 2,100 | 2,466 | 2.8 K to 2.5 K (-10.85 %) |
Oct 21 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 300 | 114 | 2,766 | 2.5 K to 2.8 K (+12.17 %) |
Oct 21 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 7.04 | 400 | 2,816 | 2,466 | 2.9 K to 2.5 K (-13.96 %) |
Oct 21 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 400 | 152 | 2,866 | 2.5 K to 2.9 K (+16.22 %) |
Oct 17 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.79 | 3,000 | 20,371 | 6,908,800 | 6.9 M to 6.9 M (-0.04 %) |
Oct 17 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.76 | 4,800 | 32,450 | 6,911,800 | 6.9 M to 6.9 M (-0.07 %) |
Oct 17 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.67 | 4,300 | 28,687 | 6,916,600 | 6.9 M to 6.9 M (-0.06 %) |
Oct 17 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.79 | 3,000 | 20,371 | 6,009,800 | 6 M to 6 M (-0.05 %) |
Oct 17 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.76 | 4,800 | 32,450 | 6,012,800 | 6 M to 6 M (-0.08 %) |
Oct 17 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.67 | 4,300 | 28,687 | 6,017,600 | 6 M to 6 M (-0.07 %) |
Oct 14 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 400 | 152 | 452,492 | |
Oct 14 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 105 | 40 | 452,892 | |
Oct 14 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 7.00 | 400 | 2,800 | 2,466 | 2.9 K to 2.5 K (-13.96 %) |
Oct 14 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 400 | 152 | 2,866 | 2.5 K to 2.9 K (+16.22 %) |
Oct 14 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 7.00 | 105 | 735 | 2,466 | 2.6 K to 2.5 K (-4.08 %) |
Oct 14 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 105 | 40 | 2,571 | 2.5 K to 2.6 K (+4.26 %) |
Oct 10 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.41 | 2,000 | 12,813 | 6,920,900 | 6.9 M to 6.9 M (-0.03 %) |
Oct 10 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.58 | 4,750 | 31,238 | 6,922,900 | 6.9 M to 6.9 M (-0.07 %) |
Oct 10 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.63 | 3,300 | 21,888 | 6,927,650 | 6.9 M to 6.9 M (-0.05 %) |
Oct 10 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.41 | 2,000 | 12,813 | 6,021,900 | 6 M to 6 M (-0.03 %) |
Oct 10 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.58 | 4,750 | 31,238 | 6,023,900 | 6 M to 6 M (-0.08 %) |
Oct 10 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.63 | 3,300 | 21,888 | 6,028,650 | 6 M to 6 M (-0.05 %) |
Oct 03 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.88 | 3,300 | 22,688 | 6,930,950 | 6.9 M to 6.9 M (-0.05 %) |
Oct 03 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.64 | 3,750 | 24,903 | 6,934,250 | 6.9 M to 6.9 M (-0.05 %) |
Oct 03 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.71 | 3,250 | 21,808 | 6,938,000 | 6.9 M to 6.9 M (-0.05 %) |
Oct 03 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.88 | 3,300 | 22,688 | 6,031,950 | 6 M to 6 M (-0.05 %) |
Oct 03 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.64 | 3,750 | 24,903 | 6,035,250 | 6 M to 6 M (-0.06 %) |
Oct 03 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.71 | 3,250 | 21,808 | 6,039,000 | 6 M to 6 M (-0.05 %) |